{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:12:55Z","timestamp":1778505175884,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ijbiomac.2021.02.155","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T16:18:14Z","timestamp":1614097094000},"page":"143-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K+ channel blockers from thermally processed scorpions"],"prefix":"10.1016","volume":"178","author":[{"given":"Chenhu","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuping","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songryong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0031-6997(24)01469-8","article-title":"Potassium channels: molecular defects, diseases, and therapeutic opportunities","volume":"52","author":"Shieh","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.02.155_bb0010","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/emboj\/17.5.1200","article-title":"Episodic ataxia type-1 mutations in the hKv1.1 cytoplasmic pore region alter the gating properties of the channel","volume":"17","author":"D\u2019Adamo","year":"1998","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.02.155_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0020","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1155\/2011\/264747","article-title":"Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population","volume":"31","author":"Ota","year":"2011","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.02.155_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/jhg.2016.154","article-title":"Novel KCNB1 mutation associated with non-syndromic intellectual disability","volume":"62","author":"Latypova","year":"2017","journal-title":"J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.02.155_bb0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Curr. Cardiol. Rev."},{"issue":"42","key":"10.1016\/j.ijbiomac.2021.02.155_bb0035","doi-asserted-by":"crossref","first-page":"32160","DOI":"10.1074\/jbc.M110.153676","article-title":"A new Kv1.2 channelopathy underlying cerebellar ataxia","volume":"285","author":"Xie","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.02.155_bb0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/cge.12542","article-title":"Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy","volume":"87","author":"Pena","year":"2015","journal-title":"Clin. Genet."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0045","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/ng.3239","article-title":"De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy","volume":"47","author":"Syrbe","year":"2015","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0050","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ana.24762","article-title":"A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia","volume":"80","author":"Helbig","year":"2016","journal-title":"Ann. Neurol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2021.02.155_bb0055","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","author":"Corbett","year":"2016","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.02.155_bb0060","first-page":"640","article-title":"Potassium channels as therapeutic targets for autoimmune disorders","volume":"6","author":"Wulff","year":"2003","journal-title":"Curr. Opin. Drug Discov. Dev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1124\/mol.104.008193","article-title":"Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases","volume":"67","author":"Beeton","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"46","key":"10.1016\/j.ijbiomac.2021.02.155_bb0070","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.02.155_bb0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.imlet.2010.06.009","article-title":"Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels","volume":"133","author":"Toldi","year":"2010","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.02.155_bb0080","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1080\/14712598.2017.1346606","article-title":"Treating autoimmune disorders with venom-derived peptides","volume":"17","author":"Shen","year":"2017","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.02.155_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.toxicon.2004.03.022","article-title":"Current views on scorpion toxins specific for K+-channels","volume":"43","author":"de la Vega","year":"2004","journal-title":"Toxicon"},{"issue":"24","key":"10.1016\/j.ijbiomac.2021.02.155_bb0090","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2174\/138161208785777441","article-title":"Animal toxins acting on voltage-gated potassium channels","volume":"14","author":"Mouhat","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0095","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuropharm.2017.07.002","article-title":"Venom-derived peptide inhibitors of voltage-gated potassium channels","volume":"127","author":"Norton","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ijbiomac.2020.01.133","article-title":"Ion channel modulation by scorpion hemolymph and its defensin ingredients highlights origin of neurotoxins in telson formed in Paleozoic scorpions","volume":"148","author":"Meng","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2021.02.155_bb0105","doi-asserted-by":"crossref","first-page":"10094","DOI":"10.1073\/pnas.89.21.10094","article-title":"Selective blockers of voltage-gated K+ channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin","volume":"89","author":"Leonard","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.ijbiomac.2021.02.155_bb0110","doi-asserted-by":"crossref","first-page":"10171","DOI":"10.1073\/pnas.86.24.10171","article-title":"Charybdotoxin inhibits proliferation and interleukin 2 production in human peripheral blood lymphocytes","volume":"86","author":"Price","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0115","doi-asserted-by":"crossref","unstructured":"S. Mouhat, V. Visan, S. Ananthakrishnan, H. Wulff, N. Andreotti, S. Grissmer, H. Darbon, M. De Waard, J.M. Sabatier, K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom, Biochem. J. 385(Pt 1) (2005) 95\u2013104.","DOI":"10.1042\/BJ20041379"},{"issue":"49","key":"10.1016\/j.ijbiomac.2021.02.155_bb0120","doi-asserted-by":"crossref","first-page":"32697","DOI":"10.1074\/jbc.273.49.32697","article-title":"ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide","volume":"273","author":"Kalman","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.02.155_bb0125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-3011.1995.tb01068.x","article-title":"Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone","volume":"46","author":"Pennington","year":"1995","journal-title":"Int. J. Pept. Protein Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.02.155_bb0130","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/mol.105.017210","article-title":"Pharmacological profiling of Orthochirus scrobiculosus toxin 1 analogs with a trimmed N-terminal domain","volume":"69","author":"Mouhat","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.02.155_bb0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103435","article-title":"Thermostable potassium channel-inhibiting neurotoxins in processed scorpion medicinal material revealed by proteomic analysis: implications of its pharmaceutical basis in traditional Chinese medicine","volume":"206","author":"Yang","year":"2019","journal-title":"J. Proteome"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.02.155_bb0145","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/pr800494a","article-title":"Different residues in channel turret determining the selectivity of ADWX-1 inhibitor peptide between Kv1.1 and Kv1.3 channels","volume":"7","author":"Yin","year":"2008","journal-title":"J. Proteome Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.02.155_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23061489","article-title":"Mouse beta-defensin 3, a defensin inhibitor of both its endogenous and exogenous potassium channels","volume":"23","author":"Zhang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.peptides.2017.09.017","article-title":"Expression of recombinant alpha-toxin BmKM9 from scorpion Buthus martensii Karsch and its functional characterization on sodium channels","volume":"99","author":"Yang","year":"2017","journal-title":"Peptides"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.02.155_bb0160","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbrc.2014.01.094","article-title":"Kv1.3 potassium channel-blocking toxin Ctri9577, novel gating modifier of Kv4.3 potassium channel from the scorpion toxin family","volume":"444","author":"Xie","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2045-3701-4-18","article-title":"Open conformation of hERG channel turrets revealed by a specific scorpion toxin BmKKx2","volume":"4","author":"Hu","year":"2014","journal-title":"Cell. Biosci."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0170","series-title":"Chinese Pharmacopoeia (Part I)","first-page":"143","author":"N.P. Commission","year":"2015"},{"issue":"27","key":"10.1016\/j.ijbiomac.2021.02.155_bb0175","doi-asserted-by":"crossref","first-page":"19058","DOI":"10.1074\/jbc.M802054200","article-title":"Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease","volume":"283","author":"Han","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2021.02.155_bb0180","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1074\/jbc.M115.680611","article-title":"Scorpion potassium channel-blocking defensin highlights a functional link with neurotoxin","volume":"291","author":"Meng","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"29","key":"10.1016\/j.ijbiomac.2021.02.155_bb0185","doi-asserted-by":"crossref","first-page":"27093","DOI":"10.1074\/jbc.M413626200","article-title":"A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpions","volume":"280","author":"Gilquin","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.02.155_bb0190","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1021\/pr100027k","article-title":"Protein-protein recognition control by modulating electrostatic interactions","volume":"9","author":"Han","year":"2010","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.02.155_bb0195","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2014.03.101","article-title":"Unusual binding mode of scorpion toxin BmKTX onto potassium channels relies on its distribution of acidic residues","volume":"447","author":"Chen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2021.02.155_bb0200","article-title":"Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.02.155_bb0205","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bcp.2008.08.018","article-title":"A selective blocker of Kv1.2 and Kv1.3 potassium channels from the venom of the scorpion Centruroides suffusus suffusus","volume":"76","author":"Corzo","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2021.02.155_bb0210","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj20030115","article-title":"The \u2018functional\u2019 dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels","volume":"377","author":"Mouhat","year":"2004","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.02.155_bb0215","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcp.2014.12.002","article-title":"Mesomartoxin, a new K(v)1.2-selective scorpion toxin interacting with the channel selectivity filter","volume":"93","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.02.155_bb0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.peptides.2011.12.012","article-title":"Identification and molecular characterization of three new K+-channel specific toxins from the Chinese scorpion Mesobuthus martensii Karsch revealing intronic number polymorphism and alternative splicing in duplicated genes","volume":"34","author":"Zeng","year":"2012","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.02.155_bb0225","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.3390\/molecules24112045","article-title":"Diverse structural features of potassium channels characterized by scorpion toxins as molecular probes","volume":"24","author":"Zhao","year":"2019","journal-title":"Molecules"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:40:28Z","timestamp":1758876028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":45,"alternative-id":["S0141813021004529"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.02.155","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K+ channel blockers from thermally processed scorpions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.02.155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}